Home › Funds › Michelson Medical Research Foundation, Inc. › CNNE
Michelson Medical Research Foundation, Inc. position in CNNE
CANNAE HLDGS INC · Consumer Discretionary
Michelson Medical Research Foundation, Inc. reported holding 480,600 shares of CNNE (CANNAE HLDGS INC) in its Q3 2026 13F filing — a position valued at US$7.4M, representing 6.55% of its reported portfolio and ranking #7 among its reported holdings. Michelson Medical Research Foundation, Inc. has disclosed CNNE holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Michelson Medical Research Foundation, Inc.'s CNNE position evolved
Michelson Medical Research Foundation, Inc. first disclosed a stake in CNNE in Q1 2026 at 480,600 shares (US$5.5M). The position peaked in Q3 2026 at 480,600 shares, worth US$7.4M. Across 3 filings, Michelson Medical Research Foundation, Inc. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 480,600 shares valued at US$7.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 480.60K | $5.46M | New |
| Q2 2026 | 480.60K | $6.92M | Hold |
| Q3 2026 | 480.60K | $7.37M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CNNE and 13F data
CNNE (CANNAE HLDGS INC) is a Consumer Discretionary company. 19 other funds we track also report a position in CNNE — the largest reported positions include CARRONADE CAPITAL MANAGEMENT, LP (US$46.5M), Newtyn Management, LLC (US$45.6M), PRIVATE MANAGEMENT GROUP INC (US$34.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CNNE
- CARRONADE CAPITAL MANAGEMENT, LP 3.23M sh · $46.51M · Q2 2026
- Newtyn Management, LLC 3.17M sh · $45.64M · Q2 2026
- PRIVATE MANAGEMENT GROUP INC 2.25M sh · $34.49M · Q3 2026
- Saba Capital Management, L.P. 1.58M sh · $22.78M · Q2 2026
- Poehling Capital Management, INC. 955.86K sh · $14.66M · Q3 2026
- Almitas Capital LLC 741.32K sh · $10.67M · Q2 2026
More on Michelson Medical Research Foundation, Inc.
FAQ
How long has Michelson Medical Research Foundation, Inc. held CNNE?
Michelson Medical Research Foundation, Inc. has disclosed CNNE holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Michelson Medical Research Foundation, Inc.'s current position in CNNE?
As of Q3 2026, Michelson Medical Research Foundation, Inc. holds 480.60K shares of CNNE (CANNAE HLDGS INC), valued at $7.37M, representing 6.55% of its reported portfolio and ranking #7.
Has Michelson Medical Research Foundation, Inc. been buying or selling CNNE?
In the latest 13F filing (Q3 2026), Michelson Medical Research Foundation, Inc. held unchanged its position in CNNE. The position peaked in Q3 2026 at 480.60K shares.
Which other funds hold CNNE?
Other major institutional holders of CNNE include CARRONADE CAPITAL MANAGEMENT, LP, Newtyn Management, LLC, PRIVATE MANAGEMENT GROUP INC, among 19 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.